Related Experiment Videos
Human lymphocyte antigens in hypertrophic cardiomyopathy
Insights
Genetic studies in hypertrophic cardiomyopathy suggest a genetic component, with HLA antigen DR4 showing increased frequency. However, no HLA linkage was found, indicating other genetic factors influence disease susceptibility.
Area of Science:
- Cardiovascular Genetics
- Immunogenetics
- Human Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) inheritance is increasingly debated, with genetic heterogeneity and non-genetic causes proposed.
- Conventional views on HCM inheritance are challenged by emerging genetic study findings.
Purpose of the Study:
- To investigate the potential genetic component in hypertrophic cardiomyopathy susceptibility.
- To examine the association between Human Leukocyte Antigen (HLA) antigens and HCM.
- To determine if a disease susceptibility gene related to the HLA region is involved in HCM.
Main Methods:
- Analysis of relative risk for specific HLA antigens in HCM patients.
- Utilizing sib pair analysis and lod scores to assess HLA linkage.
- Examining population HLA associations with HCM.
Main Results:
- A significantly increased frequency of HLA antigen DR4 was observed in individuals with hypertrophic cardiomyopathy.
- No evidence of HLA linkage to hypertrophic cardiomyopathy was found using sib pair analysis or lod scores.
- Population-based HLA associations with HCM suggest influences beyond direct HLA linkage.
Conclusions:
- Findings support a genetic component in hypertrophic cardiomyopathy susceptibility.
- The HLA region on chromosome 6 short arm is unlikely to harbor a direct disease susceptibility gene for HCM.
- Other genetic background influences likely explain population HLA associations with hypertrophic cardiomyopathy.
Abstract:
An increasing number of genetic studies in hypertrophic cardiomyopathy challenge conventional views on inheritance and suggest genetic heterogeneity or non-genetic disease. We have found changes in relative risk for some antigens with significantly increased frequency of HLA antigen DR4 in this condition. These findings are consistent with there being a genetic component in susceptibility to hypertrophic cardiomyopathy. No evidence was found for HLA linkage using either sib pair analysis or lod scores. This suggests that hypertrophic cardiomyopathy does not have a disease susceptibility gene related to the HLA region on the short arm of chromosome number six. Population HLA associations with hypertrophic cardiomyopathy must thus be explained by other influences of the genetic background on disease susceptibility.